Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    Valsartan Better Than Continuous Positive Airway Pressure Therapy in Previously Untreated Hypertensive Sleep Apnoea: Presented at CHEST 2009 - (DGDispatch)
    TopAbstracts in Hypertension 11/04/2009 - (DGNews)
    Paricalcitol Added to Hypertension Therapy Lowers Albuminuria in Patients With Diabetes and Chronic Kidney Disease: Presented at Renal Week 2009 - (DGDispatch)
    Hypertension, Markers of Inflammation In the Blood More Common in Offspring of Parents With AD - (DGNews)
    TopAbstracts in Hypertension 10/29/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    • State of the Art in Pulmonary Arterial Hypertension
    • Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment
      Treating Coronary Artery Disease in Vulnerable Adults
      Thrombotic Thrombocytopenic Purpura: The Masquerader
      Innovative Strategies in Cardiometabolic Risk Reduction

      Webcasts/CME archive

       Recent cases - Hypertension
        Hypertension
        Medical Management of a Pregnancy Woman with Moderate Renal Insufficiency and Superimposed Preclampsia
        Malignant Hypertension and Acute Aortic Dissection Associated with Caffeine-Based Ephedra-Free Dietary Supplements: A Case Report
        Giant Right Coronary Artery Aneurysm: Case Report and Literature Review
        Normalization of Systemic Arterial Hypertension Following Removal of Posterior Fossa Hemangioblastoma: A Case Report

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Sildenafil (Viagra) Effective In Treating Pulmonary Hypertension

        A DGReview of :"Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide"
        Circulation

        06/10/2002
        By Mark Pownall


        One dose of sildenafil (Viagra) is as effective as inhaled nitric oxide for patients with severe pulmonary hypertension, the results of a small Canadian study suggest.

        In a study of 13 severely ill patients, referred for possible heart-lung transplant, or as a guide to medical therapy, researchers from the University of Alberta found that the fall in pulmonary vascular resistance was similar for both drugs.

        But, patients taking a single 75 mg dose of sildenafil, either alone or in combination received other cardiovascular benefits. Sildenafil or in combination with inhaled nitric oxide increased cardiac output, and tended to reduce pulmonary capillary wedge pressure (inhaled nitric oxide increased capillary pressure).

        Systemic arterial pressure was found to be similar in all three treatment groups, and did not rise during treatment.

        Cyclic guanosine monophosphate (cGMP) levels were measured, increasing after both inhaled nitric oxide and sildenafil treatment. The levels remained elevated more than when either drug was given alone.

        The pulmonary hypertension patients were functional class III or IV, and their prognosis was poor. Nine patients had primary pulmonary hypertension; two had pulmonary arterial hypertension, and two had secondary pulmonary hypertension.

        The researchers conclude that sildenafil is an effective and selective pulmonary vasodilator, and say it may be superior to inhaled nitric oxide because it boosts cardiac output and does not increase wedge pressure. They call for further studies to assess the effect of sildenafil when given for longer periods.
        Circulation 2002; 105: 2398. "Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send